05:03 PM EDT, 08/27/2025 (MT Newswires) -- Frank Mottola, Senior Vice President, Quality, GMP Operations and Information Technology, on August 25, 2025, sold 14,000 shares in Supernus Pharmaceuticals ( SUPN ) for $623,140. Following the Form 4 filing with the SEC, Mottola has control over a total of 15,496 common shares of the company, with 15,496 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1356576/000180456725000004/xslF345X05/wk-form4_1756328373.xml